Trends in HIV-Associated End-Stage Renal Disease in the U.S., 2001–2010

The incidence of end-stage renal disease requiring dialysis in HIV-infected patients declined overall but increased in whites and individuals aged ≥65.

The rate of HIV-associated nephropathy (HIVAN) was increasing in the U.S., particularly among blacks, before the availability of combination antiretroviral therapy. Use of such therapy has greatly improved the overall outlook for HIV-infected patients, but how has it affected rates of HIVAN?

To answer this question, researchers examined the temporal trends in end-stage renal disease (ESRD; defined as use of renal replacement therapy [RRT], such as dialysis) in HIV-infected patients from 2001 through 2010. Using files from the U.S. Renal Data System, which systematically collects, analyzes, and distributes information about ESRD in the U.S., including information from Medicaid and Medicare, they analyzed basic laboratory and demographic data …

Reviewing Author

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

Trends in HIV-Associated End-Stage Renal Disease in the U.S., 2001–2010

Topics

Reviewing Author